Teriparatide Injection 20 mcg/0.5 mL Suppliers & Bulk Manufacturers

Available Forms: injection (prefilled syringe)

Available Strengths: 20 mcg/0.5 mL

Reference Brands: Forteo (USA/EU)

Category: Osteoporosis

Injection consists of the active ingredient Teriparatide. It is used to treat bone loss (osteoporosis) in men and postmenopausal women at high risk of fracture. It is a synthetic form of the parathyroid hormone naturally produced in the body.

Product Description:

This Injection is the only drug that works on bone formation, while the other drugs work on bone resorption.

Teriparatide is a medication used in the treatment and management of osteoporosis, belonging to the anabolic class of osteoporosis therapies. It is a recombinant form of the first 34 amino acids of human parathyroid hormone (PTH) and functions as a potent osteoanabolic agent. Unlike continuous high levels of PTH, which can lead to bone resorption, intermittent low-dose administration of teriparatide stimulates bone formation more than resorption, increasing bone density and strength.

Clinical studies have demonstrated the safety and efficacy of teriparatide in reducing the risk of fractures in patients with osteoporosis, particularly in postmenopausal women, men with primary osteoporosis, and individuals at high risk for fractures. The medication is typically administered daily and requires careful monitoring due to potential adverse effects and contraindications. Teriparatide’s mechanism, dosing considerations, pharmacokinetics, and potential drug interactions make it a valuable option for healthcare providers managing patients with osteoporosis. Additionally, teriparatide may be used off-label in certain conditions where enhanced bone formation is desired, further highlighting its role as a specialized anabolic therapy in bone health.